 | ||||||
| in | ||||||
| NEWS | ||||||
| Antibiotics Sales for Use in US Farms Animals Dropping for First Time CHICAGO (Reuters)—The sale and distribution of antibiotics approved for use in food-producing animals in the United States decreased by 10 percent from 2015 to 2016, a U.S. Food and Drug Administration (FDA) report said on Thursday. It was the first decline in year-to-year sales since the FDA ...
| ||||||
| Ronaldo: 'I am the best player in history' Cristiano Ronaldo has no doubt that he is "the best player in history," the Real Madrid star told France Football upon winning his fifth Ballon d'Or award on Thursday. His latest win took him level with Barcelona's Lionel Messi for the most all-time honours in football's most prestigious individual award, but ...
| ||||||
| Trial over 'Love Parade' deaths begins in Germany Eight foreigners -- from Spain, Bosnia, the Netherlands, Australia, Italy and China -- were among those killed on July 24, 2010, when panic broke out in a packed underpass that was the only entrance route to the venue for the techno music festival. The trial has been moved to a congress center in the ...
| ||||||
| Brexit Breakthrough Risks Leaving Brits in Europe 'Landlocked' "Nearly everybody I know is on course now to take on citizenship," said Fiona Godfrey, a British national who has lived and worked in Luxembourg for two decades and is co-founder of BRILL -- British Immigrants Living in Luxembourg. She will start a course in January to learn the local language and will ...
| ||||||
| WEB | ||||||
| 2 dead in 'Day of Rage' over Jerusalem, Palestinian president defiant At least two people were killed in clashes with Israeli troops on Friday when thousands of Palestinians demonstrated against U.S. President Donald Trump's recognition of Jerusalem as Israel's capital and the Palestinian president said Washington could no longer be a peace broker.
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
ShareThis
No comments:
Post a Comment